SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Texas77 who wrote (445)6/10/1998 1:02:00 PM
From: jake burns  Read Replies (1) of 1510
 
Dave, if you're a new imnr shareholder, you're very lucky, as it's all coming together this month and next month, so you won't have long to wait....yesterday's press release cleared the path (the dsmb approval and the valentine study news). I've been in imnr since january; Bob's been in longer; but we've been patiently waiting for what we're about to receive: 3rd party recognition of REMUNE's worth, and then next year, fda approval...but world (and big investors') attention will be focused on the world aids conference, and the papers presented on immune based therapy should change the focus of wall street...the annual meeting is thursday, so i hope more specifics regarding the valentine study are put forth there...in any event, i'm pretty excited for thursday and the rest of the month.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext